脓毒症和感染性休克治疗进展

被引:26
作者
刘相德
机构
[1] 美国内布拉斯加大学医学中心呼吸与重症病科
关键词
脓毒症; 感染性休克; 早期发现; 早期治疗;
D O I
10.16048/j.cnki.tccm.2014.01.017
中图分类号
R459.7 [急症、急救处理];
学科分类号
100231 [临床病理学];
摘要
脓毒症(sepsis)常并发感染性休克(septic shock)。近年来临床研究发现,脓毒症的早期诊断和治疗与患者的预后关系密切。本文就脓毒症和感染性休克治疗进展作一综述。主要内容包括:(1)尽早并正确地处置脓毒症,可以明显地降低近期和远期病死率;(2)扩容治疗(fluid resuscitation)和早期正确的抗生素治疗对脓毒症的生存率影响最大;(3)应该在24 h内控制感染原。
引用
收藏
页码:14 / 17
页数:4
相关论文
共 14 条
[1]
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012 [J].
Dellinger, R. Phillip ;
Levy, Mitchell M. ;
Rhodes, Andrew ;
Annane, Djillali ;
Gerlach, Herwig ;
Opal, Steven M. ;
Sevransky, Jonathan E. ;
Sprung, Charles L. ;
Douglas, Ivor S. ;
Jaeschke, Roman ;
Osborn, Tiffany M. ;
Nunnally, Mark E. ;
Townsend, Sean R. ;
Reinhart, Konrad ;
Kleinpell, Ruth M. ;
Angus, Derek C. ;
Deutschman, Clifford S. ;
Machado, Flavia R. ;
Rubenfeld, Gordon D. ;
Webb, Steven A. ;
Beale, Richard J. ;
Vincent, Jean-Louis ;
Moreno, Rui ;
Aitken, Leanne ;
Al Rahma, Hussain ;
Annane, Dijillali ;
Bernard, Gordon R. ;
Biban, Paolo ;
Bion, Julian F. ;
Calandra, Thierry ;
Carcillo, Joseph A. ;
Clemmer, Terry P. ;
Divatia, J. V. ;
Du, Bin ;
Fujishima, Seitaro ;
Gando, Satoshi ;
Goodyear-Bruch, Caryl ;
Guyatt, Gordon ;
Hazelzet, Jan A. ;
Hirasawa, Hiroyuki ;
Hollenberg, Steven M. ;
Jacobi, Judith ;
Jenkins, Ian ;
Jimenez, Edgar ;
Jones, Alan E. ;
Kacmarek, Robert M. ;
Kern, Winfried ;
Koh, Shin Ok ;
Kotani, Joji ;
Levy, Mitchell .
CRITICAL CARE MEDICINE, 2013, 41 (02) :580-637
[2]
Antibiotics in sepsis: Timing, appropriateness, and (of course) timely recognition of appropriateness [J].
Mikkelsen, Mark E. ;
Gaieski, David F. .
CRITICAL CARE MEDICINE, 2011, 39 (09) :2184-2186
[3]
The role of albumin as a resuscitation fluid for patients with sepsis: A systematic review and meta-analysis [J].
Delaney, Anthony P. ;
Dan, Arina ;
McCaffrey, John ;
Finfer, Simon .
CRITICAL CARE MEDICINE, 2011, 39 (02) :386-391
[4]
Hyperglycemia–related mortality in critically ill patients varies with admission diagnosis.[J].Mercedes Falciglia;Ron W. Freyberg;Peter L. Almenoff;David A. D’Alessio;Marta L. Render.Critical Care Medicine.2009, 12
[5]
Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock [J].
Russell, James A. ;
Walley, Keith R. ;
Gordon, Anthony C. ;
Cooper, James ;
Hebert, Paul C. ;
Singer, Joel ;
Holmes, Cheryl L. ;
Mehta, Sangeeta ;
Granton, John T. ;
Storms, Michelle M. ;
Cook, Deborah J. ;
Presneill, Jeffrey J. .
CRITICAL CARE MEDICINE, 2009, 37 (03) :811-818
[6]
Influence of steroids on procalcitonin and C-reactive protein in patients with COPD and community-acquired pneumonia [J].
Perren, A. ;
Cerutti, B. ;
Lepori, M. ;
Senn, V. ;
Capelli, B. ;
Duchini, F. ;
Domenighetti, G. .
INFECTION, 2008, 36 (02) :163-166
[7]
Can we prevent acute kidney injury?.[J].Ramesh Venkataraman.Critical Care Medicine.2008, 4 Su
[8]
Score-based immunoglobulin G therapy of patients with sepsis:: The SBITS study [J].
Werdan, Karl ;
Pilz, Guenter ;
Bujdoso, Oskar ;
Fraunberger, Peter ;
Neeser, Gertraud ;
Schmieder, Roland Erich ;
Viell, Burkhard ;
Marget, Walter ;
Seewald, Margret ;
Walger, Peter ;
Stuttmann, Ralph ;
Speichermann, Norbert ;
Peckelsen, Claus ;
Kurowski, Volkhard ;
Osterhues, Hans-Heinrich ;
Verner, Ljiljana ;
Neumann, Roswita ;
Mueller-Werdan, Ursula .
CRITICAL CARE MEDICINE, 2007, 35 (12) :2693-2701
[9]
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock [J].
Kumar, Arland ;
Roberts, Daniel ;
Wood, Kenneth E. ;
Light, Bruce ;
Parrillo, Joseph E. ;
Sharma, Satendra ;
Suppes, Robert ;
Feinstein, Daniel ;
Zanotti, Sergio ;
Taiberg, Leo ;
Gurka, David ;
Kumar, Aseem ;
Cheang, Mary .
CRITICAL CARE MEDICINE, 2006, 34 (06) :1589-1596
[10]
High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock [J].
Cornejo, R ;
Downey, P ;
Castro, R ;
Romero, C ;
Regueira, T ;
Vega, J ;
Castillo, L ;
Andresen, M ;
Dougnac, A ;
Bugedo, G ;
Hernandez, G .
INTENSIVE CARE MEDICINE, 2006, 32 (05) :713-722